Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.51 USD | -1.68% | -12.90% | +34.48% |
Apr. 11 | Summit Therapeutics Inc. Appoints Dr. Mostafa Ronaghi to Its Board of Directors | CI |
Apr. 09 | Illumina CFO Goswami to depart, former Summit Therapeutics exec Dhingra to succeed | RE |
Sales 2024 * | - | Sales 2025 * | - | Capitalization | 1.98B 2.46B |
---|---|---|---|---|---|
Net income 2024 * | - | Net income 2025 * | - | EV / Sales 2024 * | - |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-
| P/E ratio 2025 * |
-
| Employees | 105 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 11.85% |
Latest transcript on Summit Therapeutics Inc.
1 day | -1.68% | ||
1 week | -12.90% | ||
Current month | -15.22% | ||
1 month | -14.70% | ||
3 months | +6.04% | ||
6 months | +85.71% | ||
Current year | +34.48% |
Managers | Title | Age | Since |
---|---|---|---|
Mahkam Zanganeh
CEO | Chief Executive Officer | 52 | 20-11-10 |
Robert Duggan
CEO | Chief Executive Officer | 79 | 19-11-30 |
Director of Finance/CFO | 46 | 19-11-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Robert Duggan
CEO | Chief Executive Officer | 79 | 19-11-30 |
Robert Booth
BRD | Director/Board Member | 70 | 22-09-27 |
Director of Finance/CFO | 46 | 19-11-30 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.01% | 0 M€ | 0.00% | - | |
0.00% | 34 M€ | +1.04% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-04-18 | 3.51 | -1.68% | 1,254,262 |
24-04-17 | 3.57 | +0.85% | 1,372,805 |
24-04-16 | 3.54 | -3.15% | 1,251,831 |
24-04-15 | 3.655 | -0.27% | 887,744 |
24-04-12 | 3.665 | -9.06% | 1,361,574 |
Delayed Quote Nasdaq, April 18, 2024 at 04:00 pm EDT
More quotesQuarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+34.48% | 2.46B | |
-3.30% | 102B | |
+1.79% | 96.07B | |
-2.01% | 21.66B | |
-18.35% | 20.77B | |
-8.86% | 18.53B | |
-40.31% | 16.91B | |
-26.84% | 13.79B | |
+0.59% | 13.33B | |
+20.86% | 10.94B |
- Stock Market
- Equities
- SMMT Stock